Aug 17, 2026 11:17AM
Aug 17, 2026 11:17AM
May 15, 2026 08:00AM
Apr 30, 2026 04:05PM
Apr 2, 2026 08:00AM
Apr 2, 2026 08:00AM
Mar 31, 2026 08:05AM Cocrystal begins Phase 1b norovirus trial at Emory University
Mar 31, 2026 08:00AM
Mar 9, 2026 08:00AM
Mar 9, 2026 08:00AM
Dec 18, 2025 08:00AM
Dec 18, 2025 08:00AM
Nov 14, 2025 08:00AM
Sep 12, 2025 08:02AM Cocrystal Pharma presents CDI-988 oral norovirus antiviral data at conference
Sep 12, 2025 08:00AM
Sep 8, 2025 08:04AM
Sep 8, 2025 08:00AM
Aug 5, 2025 08:00AM
Aug 5, 2025 08:00AM
Jul 10, 2025 08:00AM
Jun 5, 2025 08:00AM Cocrystal Pharma’s Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference
May 15, 2025 08:00AM
Apr 24, 2025 08:00AM
Mar 31, 2025 08:00AM
Nov 13, 2024 08:00AM
Aug 14, 2024 08:00AM
Jun 20, 2024 08:00AM
May 14, 2024 08:45AM Noble Capital Reiterates Outperform Rating on Cocrystal Pharma (COCP)
May 13, 2024 08:00AM
May 1, 2024 08:00AM
Mar 28, 2024 08:00AM
Mar 19, 2024 08:02AM
Mar 19, 2024 08:00AM
Nov 13, 2023 08:00AM
Aug 14, 2023 08:00AM Cocrystal Pharma Reports Second Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
May 15, 2023 08:00AM
Mar 29, 2023 08:03AM
Mar 29, 2023 08:00AM
Nov 14, 2022 08:00AM
Nov 14, 2022 08:00AM
Aug 15, 2022 08:00AM
Aug 15, 2022 08:00AM Cocrystal Pharma Reports Second Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs
May 11, 2022 08:06AM
May 11, 2022 08:00AM
May 11, 2022 08:00AM
Mar 23, 2022 04:05PM
Mar 23, 2022 04:05PM
Mar 3, 2022 08:00AM
Mar 3, 2022 08:00AM Cocrystal Pharma to Participate in Upcoming Investment Conferences
Jan 27, 2022 08:02AM

329,911 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All